bpc-157 subcutaneous vs intramuscular administration Peptide is bpc 157 subcutaneous or

10 mg / 3 mL = 3.33 mg/mL 2,500 mcg / 3,333 mcg per mL = 0.75 mL 0.75 mL x 100 = 75 U-100 units Stacking and protocol tracking Recovery protocols often pair TB-500 with BPC-157 on overlapping schedules

Current subcutaneous injection technique job aid

How to use Integrative Peptides BPC-157 For those who decide to try these products, following optimal usage protocols maximizes the potential for benefit

Pain typically flares during squatting, climbing stairs, or sitting for long periods with bent knees

Dosage and administration Typical protocols in the literature and clinical practice use subcutaneous injection near the injury site, though oral and intramuscular routes are also used

The upshot is that these peptides can now be marketed as FDA-approved implying that they are safe and efficacious - when clinical trials to prove this have not been done